TY - JOUR
T1 - Failure of acute saralasin to reverse chronic hypertension in fetal lambs
AU - Anderson, D. F.
AU - Binder, N. D.
PY - 1991
Y1 - 1991
N2 - Upper body arterial hypertension developed in 12 fetal lambs after chronic suprarenal aortic blood flow reduction. Sixty minutes after blood flow reduction, intravenous saralasin infusion was able to reduce upper body mean arterial blood pressure to control levels. Although saralasin infusion was able to decrease upper body arterial blood pressure after 1 day of hypertension, it was not able to return blood pressure to control levels. Three or more days later, saralasin was unable to cause a significant reduction in upper body arterial blood pressure. We conclude that, although the renin-angiotensin system has a role in maintaining the elevated blood pressure after ≥1 day of suprarenal aortic blood flow reduction, some other mechanism also participates. We have ruled out a role for changing blood volume, and our results suggest that an elevation of plasma catecholamines is not responsible. Some other pathway for fluid regulation available to the fetus may be responsible.
AB - Upper body arterial hypertension developed in 12 fetal lambs after chronic suprarenal aortic blood flow reduction. Sixty minutes after blood flow reduction, intravenous saralasin infusion was able to reduce upper body mean arterial blood pressure to control levels. Although saralasin infusion was able to decrease upper body arterial blood pressure after 1 day of hypertension, it was not able to return blood pressure to control levels. Three or more days later, saralasin was unable to cause a significant reduction in upper body arterial blood pressure. We conclude that, although the renin-angiotensin system has a role in maintaining the elevated blood pressure after ≥1 day of suprarenal aortic blood flow reduction, some other mechanism also participates. We have ruled out a role for changing blood volume, and our results suggest that an elevation of plasma catecholamines is not responsible. Some other pathway for fluid regulation available to the fetus may be responsible.
KW - Angiotensin
KW - Fetal blood pressure
KW - Fetal hypertension
UR - https://www.scopus.com/pages/publications/0025735193
UR - https://www.scopus.com/pages/publications/0025735193#tab=citedBy
U2 - 10.1152/ajpregu.1991.260.4.r811
DO - 10.1152/ajpregu.1991.260.4.r811
M3 - Article
C2 - 2012252
AN - SCOPUS:0025735193
SN - 0002-9513
VL - 260
SP - R811-R816
JO - American Journal of Physiology
JF - American Journal of Physiology
IS - 4 29/4
ER -